Concepedia

Publication | Closed Access

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

190

Citations

31

References

2020

Year

Abstract

Elagolix with add-back therapy was effective in reducing heavy menstrual bleeding in women with uterine fibroids. (Funded by AbbVie; Elaris UF-1 and Elaris UF-2 ClinicalTrials.gov numbers, NCT02654054 and NCT02691494.).

References

YearCitations

Page 1